631 related articles for article (PubMed ID: 13677416)
1. Challenges for the management of hypertension in low-resource settings.
Mendis S
Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries.
Mendis S; Lindholm LH; Mancia G; Whitworth J; Alderman M; Lim S; Heagerty T
J Hypertens; 2007 Aug; 25(8):1578-82. PubMed ID: 17620952
[TBL] [Abstract][Full Text] [Related]
3. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
Ruilope LM; Segura J
Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
[TBL] [Abstract][Full Text] [Related]
5. Global preventive policies. Strategies at European and worldwide level.
Kotseva K
Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
[TBL] [Abstract][Full Text] [Related]
6. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
[TBL] [Abstract][Full Text] [Related]
7. A heart-healthy and "stroke-free" world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa.
Mensah GA
Ethn Dis; 2003; 13(2 Suppl 2):S4-12. PubMed ID: 13677406
[TBL] [Abstract][Full Text] [Related]
8. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings.
Mendis S; Lindholm LH; Anderson SG; Alwan A; Koju R; Onwubere BJ; Kayani AM; Abeysinghe N; Duneas A; Tabagari S; Fan W; Sarraf-Zadegan N; Nordet P; Whitworth J; Heagerty A
J Clin Epidemiol; 2011 Dec; 64(12):1451-62. PubMed ID: 21530172
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.
Emberson J; Whincup P; Morris R; Walker M; Ebrahim S
Eur Heart J; 2004 Mar; 25(6):484-91. PubMed ID: 15039128
[TBL] [Abstract][Full Text] [Related]
10. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
Gaziano TA; Steyn K; Cohen DJ; Weinstein MC; Opie LH
Circulation; 2005 Dec; 112(23):3569-76. PubMed ID: 16330698
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factor prevalence among men in a large industry of northern India.
Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS
Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439
[TBL] [Abstract][Full Text] [Related]
15. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
Rabinowitz I; Tamir A
Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cardiovascular disease in Canada.
Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
[TBL] [Abstract][Full Text] [Related]
17. Control of human parasitic diseases: Context and overview.
Molyneux DH
Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
[TBL] [Abstract][Full Text] [Related]
19. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice.
Eaton CB; McQuade W; Glupczynski D
Fam Med; 1994 Oct; 26(9):587-92. PubMed ID: 7843510
[TBL] [Abstract][Full Text] [Related]
20. Monitoring cardiovascular disease in Zimbabwe: a review of needs and options.
Razum O
Cent Afr J Med; 1996 Apr; 42(4):120-4. PubMed ID: 8791870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
